Viridian Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRDN and other ETFs, options, and stocks.

About VRDN

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. 

CEO
Stephen Frank Mahoney
CEOStephen Frank Mahoney
Employees
96
Employees96
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2006
Founded2006
Employees
96
Employees96

VRDN Key Statistics

Market cap
897.58M
Market cap897.58M
Price-Earnings ratio
-2.69
Price-Earnings ratio-2.69
Dividend yield
—
Dividend yield—
Average volume
797.54K
Average volume797.54K
High today
$14.77
High today$14.77
Low today
$14.00
Low today$14.00
Open price
$14.77
Open price$14.77
Volume
809.19K
Volume809.19K
52 Week high
$29.65
52 Week high$29.65
52 Week low
$10.93
52 Week low$10.93

Analyst ratings

100%

of 15 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.